4-[[(2S)-1-cyclobutylidene-2-methyl-3-[4-[4-[2-[pentyl(propyl)amino]ethyl]piperazin-1-yl]phenoxy]propyl]amino]-2-(trifluoromethyl)benzonitrile;2-methylbutane;3-methyl-6-methylidenepiperidin-2-one;1-(4-methylphenyl)propan-2-one;propane
C61H93F3N6O3 — CID 155713585
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[[(2S)-1-cyclobutylidene-2-methyl-3-[4-[4-[2-[pentyl(propyl)amino]ethyl]piperazin-1-yl]phenoxy]propyl]amino]-2-(trifluoromethyl)benzonitrile;2-methylbutane;3-methyl-6-methylidenepiperidin-2-one;1-(4-methylphenyl)propan-2-one;propane
4-[[(2S)-1-cyclobutylidene-2-methyl-3-[4-[4-[2-[pentyl(propyl)amino]ethyl]piperazin-1-yl]phenoxy]propyl]amino]-2-(trifluoromethyl)benzonitrile;2-methylbutane;3-methyl-6-methylidenepiperidin-2-one;1-(4-methylphenyl)propan-2-one;propane (PubChem CID 155713585) has the molecular formula C61H93F3N6O3 and a molecular weight of 1015.45 g/mol. Its IUPAC name is 4-[[(2S)-1-cyclobutylidene-2-methyl-3-[4-[4-[2-[pentyl(propyl)amino]ethyl]piperazin-1-yl]phenoxy]propyl]amino]-2-(trifluoromethyl)benzonitrile;2-methylbutane;3-methyl-6-methylidenepiperidin-2-one;1-(4-methylphenyl)propan-2-one;propane.
Molecular Properties
| Compound Name | 4-[[(2S)-1-cyclobutylidene-2-methyl-3-[4-[4-[2-[pentyl(propyl)amino]ethyl]piperazin-1-yl]phenoxy]propyl]amino]-2-(trifluoromethyl)benzonitrile;2-methylbutane;3-methyl-6-methylidenepiperidin-2-one;1-(4-methylphenyl)propan-2-one;propane |
|---|---|
| PubChem CID | 155713585 |
| Molecular Formula | C61H93F3N6O3 |
| Molecular Weight | 1015.45 g/mol |
| Exact Mass | 1014.73 |
| IUPAC Name | 4-[[(2S)-1-cyclobutylidene-2-methyl-3-[4-[4-[2-[pentyl(propyl)amino]ethyl]piperazin-1-yl]phenoxy]propyl]amino]-2-(trifluoromethyl)benzonitrile;2-methylbutane;3-methyl-6-methylidenepiperidin-2-one;1-(4-methylphenyl)propan-2-one;propane |
| SMILES | C=C1CCC(C)C(=O)N1.CC(=O)Cc1ccc(C)cc1.CCC.CCC(C)C.CCCCCN(CCC)CCN1CCN(c2ccc(OC[C@@H](C)C(Nc3ccc(C#N)c(C(F)(F)F)c3)=C3CCC3)cc2)CC1 |
| InChI | InChI=1S/C36H50F3N5O.C10H12O.C7H11NO.C5H12.C3H8/c1-4-6-7-18-42(17-5-2)19-20-43-21-23-44(24-22-43)32-13-15-33(16-14-32)45-27-28(3)35(29-9-8-10-29)41-31-12-11-30(26-40)34(25-31)36(37,38)39;1-8-3-5-10(6-4-8)7-9(2)11;1-5-3-4-6(2)8-7(5)9;1-4-5(2)3;1-3-2/h11-16,25,28,41H,4-10,17-24,27H2,1-3H3;3-6H,7H2,1-2H3;5H,2-4H2,1H3,(H,8,9);5H,4H2,1-3H3;3H2,1-2H3/t28-;;;;/m1..../s1 |
| InChIKey | UJOSQUNDWUNOFP-VSZUHEEPSA-N |
| XLogP | 14.81 |
| TPSA | 100.94 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 19 |
| Heavy Atoms | 73 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1015.45 |
| LogP ≤ 5 | 14.81 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'anil_di_alk_C(246)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155713585 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.